Amalgamated Bank’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Amalgamated Bank’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,477	Closed	-$6K	–	3191
2023 Q1	$6K	Buy	13,477 +2,240	+20%	+$1.72K	﹤0.01%	2892
2022 Q4	$13K	Hold	11,237	–	–	﹤0.01%	2846
2022 Q3	$26K	Buy	11,237 +6,780	+152%	+$17.8K	﹤0.01%	2739
2022 Q2	$10K	Buy	+4,457	New	+$30.9K	﹤0.01%	3001

Other funds holding GRNA

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CGC

Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return

Amalgamated Bank's GRNA Position: Q2 2023 in Review

Amalgamated Bank sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q2 2023, closing a stake of 13,477 shares — an estimated $6K sold.

Amalgamated Bank first reported a position in GRNA in Q2 2022 and held it in 4 quarters. The position peaked at $26K in Q3 2022. 48 funds tracked by Wall St. Rank hold GRNA as of Q2 2023.

Amalgamated Bank reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q2 2023 after selling out during the quarter.
Amalgamated Bank sold 13,477 GreenLight Biosciences Holdings, PBC Common Stock shares in Q2 2023, an estimated $6K.
Amalgamated Bank first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2022 and held it in 4 quarters.
Amalgamated Bank's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $26K in Q3 2022.
48 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q2 2023.

Based on Amalgamated Bank's 13F filing for Q2 2023, filed 11 Aug 2023.